Menu
GWAS Study

Predicting physiological aging rates from a range of quantitative traits using machine learning.

Sun ED, Qian Y, Oppong R et al.

34718232 PubMed ID
GWAS Study Type
6100 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

SE
Sun ED
QY
Qian Y
OR
Oppong R
BT
Butler TJ
ZJ
Zhao J
CB
Chen BH
TT
Tanaka T
KJ
Kang J
SC
Sidore C
CF
Cucca F
BS
Bandinelli S
AG
Abecasis GR
GM
Gorospe M
FL
Ferrucci L
SD
Schlessinger D
GI
Goldberg I
DJ
Ding J
Chapter II

Abstract

Summary of the research findings

It is widely thought that individuals age at different rates. A method that measures "physiological age" or physiological aging rate independent of chronological age could therefore help elucidate mechanisms of aging and inform an individual's risk of morbidity and mortality. Here we present machine learning frameworks for inferring individual physiological age from a broad range of biochemical and physiological traits including blood phenotypes (e.g., high-density lipoprotein), cardiovascular functions (e.g., pulse wave velocity) and psychological traits (e.g., neuroticism) as main groups in two population cohorts SardiNIA (~6,100 participants) and InCHIANTI (~1,400 participants). The inferred physiological age was highly correlated with chronological age (R2 > 0.8). We further defined an individual's physiological aging rate (PAR) as the ratio of the predicted physiological age to the chronological age. Notably, PAR was a significant predictor of survival, indicating an effect of aging rate on mortality. Our trait-based PAR was correlated with DNA methylation-based epigenetic aging score (r = 0.6), suggesting that both scores capture a common aging process. PAR was also substantially heritable (h2~0.3), and a subsequent genome-wide association study of PAR identified significant associations with two genetic loci, one of which is implicated in telomerase activity. Our findings support PAR as a proxy for an underlying whole-body aging mechanism. PAR may thus be useful to evaluate the efficacy of treatments that target aging-related deficits and controllable epidemiological factors.

up to 6,100 European ancestry individuals

Chapter III

Study Statistics

Key metrics and study information

6100
Total Participants
GWAS
Study Type
No
Replicated
European
Ancestry
Italy
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.